The Filings Report

Penumbra, Inc.

PENNYSECIK 1321732Healthcare / Medical Devicesfiscal year ends December51 quarters since 2014

Revenue, Q3 FY2026
$410M
+15.6% on Q3 FY2025
Net income
$42M
−7.8% on Q3 FY2025
Free cash flow
$26M
−37.2% on Q3 FY2025
Diluted EPS
$1.07
−8.5% on Q3 FY2025
Revenue, TTM
$1.6B
trailing four quarters
Net margin, TTM
10.1%
net income $157M
Free cash flow, TTM
$200M
$261M less $61M capex
Cash and equivalents
$254M
long-term debt —, Sep 30, 2026
Shares, 12-month change
+0.6%
39M shares, Sep 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
—
no yield
Market value
$12.7B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 29, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Penumbra, Inc. reported revenue of $410M, +15.6% on Q3 FY2025, and net income of $42M (−7.8%). Operating margin was 12.4%. Free cash flow, operating cash flow less capital expenditures, was $26M ($42M less $15M). Diluted earnings per share were $1.07.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 29, 2026.

Revenue and net incomeRevenueNet income
−$200M$0$200M$400M$600MQ4'22, Revenue: $221MQ4'22, Net income: $4MQ4'22Q1'23, Revenue: $241MQ1'23, Net income: $9MQ1'23Q2'23, Revenue: $261MQ2'23, Net income: $19MQ2'23Q3'23, Revenue: $271MQ3'23, Net income: $9MQ3'23Q4'23, Revenue: $285MQ4'23, Net income: $54MQ4'23Q1'24, Revenue: $279MQ1'24, Net income: $11MQ1'24Q2'24, Revenue: $299MQ2'24, Net income: −$60MQ2'24Q3'24, Revenue: $301MQ3'24, Net income: $30MQ3'24Q4'24, Revenue: $316MQ4'24, Net income: $34MQ4'24Q1'25, Revenue: $324MQ1'25, Net income: $39MQ1'25Q2'25, Revenue: $339MQ2'25, Net income: $45MQ2'25Q3'25, Revenue: $355MQ3'25, Net income: $46MQ3'25Q4'25, Revenue: $385MQ4'25, Net income: $47MQ4'25Q1'26, Revenue: $375MQ1'26, Net income: $33MQ1'26Q2'26, Revenue: $390MQ2'26, Net income: $35MQ2'26Q3'26, Revenue: $410MQ3'26, Net income: $42MQ3'26−$200M$0$200M$400M$600MQ4'22, Revenue: $221MQ4'22, Net income: $4MQ1'23, Revenue: $241MQ1'23, Net income: $9MQ1'23Q2'23, Revenue: $261MQ2'23, Net income: $19MQ3'23, Revenue: $271MQ3'23, Net income: $9MQ3'23Q4'23, Revenue: $285MQ4'23, Net income: $54MQ1'24, Revenue: $279MQ1'24, Net income: $11MQ1'24Q2'24, Revenue: $299MQ2'24, Net income: −$60MQ3'24, Revenue: $301MQ3'24, Net income: $30MQ3'24Q4'24, Revenue: $316MQ4'24, Net income: $34MQ1'25, Revenue: $324MQ1'25, Net income: $39MQ1'25Q2'25, Revenue: $339MQ2'25, Net income: $45MQ3'25, Revenue: $355MQ3'25, Net income: $46MQ3'25Q4'25, Revenue: $385MQ4'25, Net income: $47MQ1'26, Revenue: $375MQ1'26, Net income: $33MQ1'26Q2'26, Revenue: $390MQ2'26, Net income: $35MQ3'26, Revenue: $410MQ3'26, Net income: $42MQ3'26

Net income losses drawn in red.

Free cash flow
−$20M$0$20M$40M$60M$80MQ4'22, Free cash flow: −$2MQ4'22Q1'23, Free cash flow: $9MQ1'23Q2'23, Free cash flow: $13MQ2'23Q3'23, Free cash flow: $28MQ3'23Q4'23, Free cash flow: $33MQ4'23Q1'24, Free cash flow: $32MQ1'24Q2'24, Free cash flow: $18MQ2'24Q3'24, Free cash flow: $51MQ3'24Q4'24, Free cash flow: $46MQ4'24Q1'25, Free cash flow: $36MQ1'25Q2'25, Free cash flow: $29MQ2'25Q3'25, Free cash flow: $42MQ3'25Q4'25, Free cash flow: $68MQ4'25Q1'26, Free cash flow: $73MQ1'26Q2'26, Free cash flow: $33MQ2'26Q3'26, Free cash flow: $26MQ3'26−$20M$0$20M$40M$60M$80MQ4'22, Free cash flow: −$2MQ1'23, Free cash flow: $9MQ1'23Q2'23, Free cash flow: $13MQ3'23, Free cash flow: $28MQ3'23Q4'23, Free cash flow: $33MQ1'24, Free cash flow: $32MQ1'24Q2'24, Free cash flow: $18MQ3'24, Free cash flow: $51MQ3'24Q4'24, Free cash flow: $46MQ1'25, Free cash flow: $36MQ1'25Q2'25, Free cash flow: $29MQ3'25, Free cash flow: $42MQ3'25Q4'25, Free cash flow: $68MQ1'26, Free cash flow: $73MQ1'26Q2'26, Free cash flow: $33MQ3'26, Free cash flow: $26MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$200M$400M$600MQ4'22, Cash and equivalents: $70MQ4'22Q1'23, Cash and equivalents: $95MQ1'23Q2'23, Cash and equivalents: $114MQ2'23Q3'23, Cash and equivalents: $101MQ3'23Q4'23, Cash and equivalents: $167MQ4'23Q1'24, Cash and equivalents: $223MQ1'24Q2'24, Cash and equivalents: $288MQ2'24Q3'24, Cash and equivalents: $280MQ3'24Q4'24, Cash and equivalents: $324MQ4'24Q1'25, Cash and equivalents: $376MQ1'25Q2'25, Cash and equivalents: $422MQ2'25Q3'25, Cash and equivalents: $321MQ3'25Q4'25, Cash and equivalents: $187MQ4'25Q1'26, Cash and equivalents: $241MQ1'26Q2'26, Cash and equivalents: $205MQ2'26Q3'26, Cash and equivalents: $254MQ3'26$0$200M$400M$600MQ4'22, Cash and equivalents: $70MQ1'23, Cash and equivalents: $95MQ1'23Q2'23, Cash and equivalents: $114MQ3'23, Cash and equivalents: $101MQ3'23Q4'23, Cash and equivalents: $167MQ1'24, Cash and equivalents: $223MQ1'24Q2'24, Cash and equivalents: $288MQ3'24, Cash and equivalents: $280MQ3'24Q4'24, Cash and equivalents: $324MQ1'25, Cash and equivalents: $376MQ1'25Q2'25, Cash and equivalents: $422MQ3'25, Cash and equivalents: $321MQ3'25Q4'25, Cash and equivalents: $187MQ1'26, Cash and equivalents: $241MQ1'26Q2'26, Cash and equivalents: $205MQ3'26, Cash and equivalents: $254MQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Penumbra, Inc. income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Jul 29, 2025Q1 FY2025ended Mar 31, 2025filed Apr 23, 2025Q4 FY2024ended Dec 31, 2024filed Feb 18, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue410390375385355339324316+15.6%
Cost of revenue130125121123114115108105+13.6%
Gross profit280265253262240224216211+16.6%
Research and development—————————
Selling, general and administrative204199193181169160153148+20.9%
Operating income5141385949414043+3.9%
Other income (expense)65343442+59.9%
Pretax income5646426452454444+7.6%
Income tax141191660511+116.8%
Net income4235334746453934−7.8%
Diluted EPS ($)1.070.880.82—1.171.151.00—−8.5%
Diluted shares (millions)404040—393939——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Penumbra, Inc. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Jul 29, 2025Q1 FY2025ended Mar 31, 2025filed Apr 23, 2025Q4 FY2024ended Dec 31, 2024filed Feb 18, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents254205241187321422376324−20.8%
Short-term investments4194543743581493316+180.9%
Total current assets1,3771,3441,2751,2171,1421,0651,000951+20.6%
Total assets2,0251,9751,8981,8271,7441,6751,5931,533+16.1%
Total current liabilities234234212183170158159158+37.9%
Long-term debt—————————
Total liabilities442444425399386381380382+14.5%
Stockholders’ equity1,5841,5311,4741,4281,3591,2941,2131,151+16.5%
Shares outstanding (millions)3939393939393939—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Penumbra, Inc. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Jul 29, 2025Q1 FY2025ended Mar 31, 2025filed Apr 23, 2025Q4 FY2024ended Dec 31, 2024filed Feb 18, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow4246878658454951−28.8%
Capital expenditures151414181616135−7.0%
Free cash flow (CFO − capex)2633736842293646−37.2%
Depreciation and amortization56542654+119.7%
Share repurchases———0———0—
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 25, 2026.

Income statement

Penumbra, Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 18, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 23, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 23, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Mar 8, 2016FY2014ended Dec 31, 2014filed Nov 12, 2015FY2013ended Dec 31, 2013filed Nov 12, 2015
Revenue1,4041,1951,05984774856054744533426318612689
Cost of revenue46144037631227222217515211792624331
Gross profit9427556835354753383722932171711248358
Research and development———————363224181614
Selling, general and administrative6635745064503782872732261841481026445
Operating income1899746(8)(39)48(1)1(1)43(1)
Other income (expense)16126(2)(3)00(1)(1)(2)(1)00
Pretax income20521804(11)(38)5022(1)43(1)
Income tax277(11)6(13)(19)3(4)(4)(16)21(5)
Net income1781491(2)5(16)487515224
Diluted EPS ($)4.520.362.32(0.05)0.14(0.44)1.340.180.130.440.08(0.18)0.14
Diluted shares (millions)39393938383636363533144,609*6,501*

Balance sheet

Penumbra, Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 18, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 23, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 23, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Mar 8, 2016FY2014ended Dec 31, 2014filed Nov 12, 2015FY2013ended Dec 31, 2013filed Nov 12, 2015
Cash and equivalents187324167705970736851132034
Short-term investments35816122118195195———————
Total current assets1,217951915756681618463410382264244115—
Total assets1,8271,5331,5561,3711,244823666558477308264121—
Total current liabilities183158151145123106917052362821—
Long-term debt—————————————
Total liabilities39938237737229018518013576423122—
Stockholders’ equity1,4281,1511,179999954641486422400267233(12)(8)
Shares outstanding (millions)3939393838363535343230——

Cash flow statement

Penumbra, Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 18, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 23, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 23, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Mar 8, 2016FY2014ended Dec 31, 2014filed Nov 12, 2015FY2013ended Dec 31, 2013filed Nov 12, 2015
Operating cash flow23916897(56)10(33)272913(13)(21)(6)(3)
Capital expenditures64211519212522101314541
Free cash flow (CFO − capex)17514782(75)(12)(58)5190(26)(26)(10)(4)
Depreciation and amortization1724272416138642211
Share repurchases010000—————————
Dividends paid—————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 3, 2024 to November 3, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$11M
32 sales by 5 insiders; officers and directors $11M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 15, 2026Narayan ShruthiPresidenttax withholding1,367$321.20$439K31,283Oct 16, 2026
Sep 15, 2026Narayan ShruthiPresidenttax withholding1,230$318.43$392K32,650Sep 17, 2026
Aug 17, 2026Narayan ShruthiPresidentaward3,060$0.00—33,880Aug 19, 2026
May 19, 2026Elsesser AdamCEO, Directorgiftindirect77,000$0.00—683,042May 21, 2026
Apr 2, 2026Grewal HarpreetDirectoropen-market sale10b5-1100$328.22$33K8,719Apr 6, 2026
Mar 15, 2026Narayan ShruthiPresidenttax withholding117$336.18$39K30,755Mar 17, 2026
Mar 15, 2026Roberts JohannaEVP, Gen. Counsel & Secretarytax withholding186$336.18$63K67,298Mar 17, 2026
Mar 15, 2026Yuen MaggieChief Financial Officertax withholding186$336.18$63K18,167Mar 17, 2026
Mar 15, 2026Shiu LambertChief Accounting Officertax withholding150$336.18$50K39,323Mar 17, 2026
Mar 2, 2026Yuen MaggieChief Financial Officeropen-market sale10b5-12,432$342.30$832K18,353Mar 4, 2026
Feb 17, 2026Roberts JohannaEVP, Gen. Counsel & Secretaryaward2,630$0.00—67,484Feb 18, 2026
Feb 17, 2026Yuen MaggieChief Financial Officeraward2,630$0.00—20,785Feb 18, 2026
Feb 17, 2026Shiu LambertChief Accounting Officeraward2,300$0.00—39,473Feb 18, 2026
Feb 17, 2026Narayan ShruthiPresidentaward2,630$0.00—30,872Feb 18, 2026
Feb 15, 2026Roberts JohannaEVP, Gen. Counsel & Secretarytax withholding482$339.30$164K64,854Feb 18, 2026
Feb 15, 2026Yuen MaggieChief Financial Officertax withholding481$339.30$163K18,155Feb 18, 2026
Feb 15, 2026Shiu LambertChief Accounting Officertax withholding412$339.30$140K37,173Feb 18, 2026
Feb 15, 2026Narayan ShruthiPresidenttax withholding705$339.30$239K28,242Feb 18, 2026
Feb 13, 2026Grewal HarpreetDirectoraward589$0.00—8,819Feb 18, 2026
Feb 13, 2026Bose AraniDirectoraward589$0.00—1,147Feb 18, 2026
Feb 13, 2026Leeds JanetDirectoraward589$0.00—6,639Feb 18, 2026
Feb 13, 2026O'Rourke BridgetDirectoraward589$0.00—5,962Feb 18, 2026
Feb 13, 2026Sarna SurbhiDirectoraward589$0.00—4,293Feb 18, 2026
Feb 13, 2026Wilder ThomasDirectoraward589$0.00—589Feb 18, 2026
Feb 13, 2026Roberts JohannaEVP, Gen. Counsel & Secretaryaward2,630$0.00—65,336Feb 18, 2026

Full insider history for Penumbra, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Penumbra, Inc, CIK 1321732 on EDGAR
Extract generated
November 4, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: depreciation amortization FY2016
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2022
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNet
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: AvailableForSaleSecuritiesDebtSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: not filed
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated November 4, 2026.

JSON file
/data/financials/PEN.json